Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Microb Drug Resist ; 30(5): 210-213, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38346314

RESUMO

There is an emerging fluconazole resistance in Candida parapsilosis in recent years. The leading mechanism causing azole resistance in C. parapsilosis is the Y132F codon alteration in the ERG11 gene which encodes the target enzyme of azole drugs. In this study, we evaluated the sensitivity, compatibility, and specificity of a novel tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) method for rapid detection of the Y132F mutation in fluconazole nonsusceptible C. parapsilosis. Antifungal susceptibility tests for detection of fluconazole resistance were performed by broth microdilution according to the CLSI guidelines. All susceptible and nonsusceptible C. parapsilosis isolates were analyzed for ERG11 mutations with Sanger sequencing. T-ARMS-PCR was fully concordant with the Sanger sequencing (100% of sensitivity and specificity) for detection of Y132F mutations. T-ARMS-PCR method could be a rapid, simple, accurate, and economical assay in the early detection of the most common cause of fluconazole resistance in C. parapsilosis isolates. In routine laboratories with high C. parapsilosis isolation rates, performing the T-ARMS-PCR for early detection of the most common reason of fluconazole resistance in C. parapsilosis, could be a life-saving approach for directing antifungal therapy before obtaining the definitive antifungal susceptibility tests results.


Assuntos
Antifúngicos , Candida parapsilosis , Farmacorresistência Fúngica , Fluconazol , Testes de Sensibilidade Microbiana , Mutação , Reação em Cadeia da Polimerase , Fluconazol/farmacologia , Candida parapsilosis/genética , Candida parapsilosis/efeitos dos fármacos , Farmacorresistência Fúngica/genética , Antifúngicos/farmacologia , Testes de Sensibilidade Microbiana/métodos , Humanos , Reação em Cadeia da Polimerase/métodos , Proteínas Fúngicas/genética , Primers do DNA/genética , Candidíase/microbiologia , Candidíase/tratamento farmacológico
2.
Angew Chem Int Ed Engl ; 53(32): 8392-6, 2014 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-24962346

RESUMO

Disulfide-containing IgG-, Fc-, or albumin-based prodrugs that rely on FcRn-trafficking by endothelial cells for prolonged circulation in the body might be hampered by premature bio-reduction processes during FcRn-mediated recycling events. A detailed bio-reduction analysis of redox-sensitive albumin conjugates in two FcRn-expressing cell lines has been performed. The obtained results indicate that the FcRn-mediated recycling pathway is not (or is only poorly) bio-reducing.


Assuntos
Albuminas/química , Antígenos de Histocompatibilidade Classe I/genética , Receptores Fc/genética , Sistemas de Liberação de Medicamentos , Humanos , Oxirredução
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...